Adverse reactions to drugs are a significant cause of death and injuryin infants and children younger than 2 years, according to a report in theNovember issue of Pediatrics. The potential for adverse reactions in childrenis higher than it is in adults because young children have immature detoxificationmechanisms and because doses must be adjusted over a very wide range ofbody size and weight.
FDA Accepts NDA for Zoliflodacin, Potentially First Gonorrhea Antibiotic in Decades
June 13th 2025The FDA has accepted a New Drug Application for zoliflodacin, a first-in-class oral antibiotic for treating uncomplicated gonorrhea, offering a potential new option amid rising antibiotic resistance.
Read More